Headache

Articles Available on Medscape

• An Exploratory Study Evaluating the 30 Medications Most Commonly Associated With Headaches in the FDA Adverse Event Reporting System
  A new study has identified the top drugs most commonly associated with headache as a medication side effect.

  March 27, 2023

• Post-Vaccination Headache Reporting
  Headaches are often reported as a possible side effect after getting a vaccine. How common, and how serious, are they?

  March 20, 2023

• Migraine Treatment in Pregnancy
  A new survey provides insight into the practice patterns of women's healthcare providers as they treat pregnant women with migraine.

  March 13, 2023

• Eptinezumab for Adolescents With Chronic Refractory Headache
  Is the CGRP monoclonal antibody eptinezumab safe and effective treatment for chronic, refractory headache in adolescents?

  March 06, 2023

• Once-daily Oral Atogepant for the Long-term Preventive Treatment of Migraine
  This trial assessed the long-term safety, tolerability, and efficacy of oral once-daily atogepant in adults with migraine during a 52-week period.

  February 27, 2023

Table of Contents

2023 -

• Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study. 

  February 16, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Impact of preventive pill-based treatment on migraine days: A secondary outcome study of the Childhood and Adolescent Migraine Prevention (CHAMP) trial and a comparison of self-report to nosology-derived assessments. 

  February 09, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Patient preferences for attributes of injected or infused preventive migraine medications: Findings from a discrete choice experiment. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Lifetime history of an anxiety or depression disorder and adherence to medications used for the acute treatment of migraine. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Use of combined hormonal contraception and stroke: A case-control study of the impact of migraine type and estrogen dose on ischemic stroke risk. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Prolactin in headache and migraine: A systematic review of preclinical studies. 

  February 08, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Predictors of treatment-response to caffeine combination products, acetaminophen, acetylsalicylic acid (aspirin), and nonsteroidal anti-inflammatory drugs in acute treatment of episodic migraine. 

  February 07, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Headache education by leaflet distribution during COVID-19 vaccination and school-based on-demand e-learning: Itoigawa Geopark Headache Awareness Campaign. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Characterization of trigeminal C-fiber reactivity through capsaicin-induced release of calcitonin gene-related peptide. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Migraine, inflammatory bowel disease and celiac disease: A Mendelian randomization study. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Perceived severity of Visual Snow Syndrome is associated with visual allodynia. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial. 

  January 27, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Virtual issue: Recent advances in pediatric headache: Bridging the data gap. 

  January 18, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Phase Ib, open-label, fixed-sequence, drug-drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine. 

  January 05, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]

• Reviewer acknowledgment for 2022. 

  January 01, 2023

  • [ MEDLINE Abstract ]
  • [ Full-text from Publisher's Site ]